Lipocine Inc. (LPCN)
NASDAQ: LPCN · Real-Time Price · USD
9.80
+0.43 (4.59%)
At close: Feb 20, 2026, 4:00 PM EST
9.99
+0.19 (1.94%)
After-hours: Feb 20, 2026, 7:41 PM EST
Lipocine Market Cap
Lipocine has a market cap or net worth of $54.41 million as of February 20, 2026. Its market cap has increased by 129.57% in one year.
Market Cap
54.41M
Enterprise Value
39.44M
1-Year Change
129.57%
Ranking
Category
Stock Price
$9.80
Market Cap Chart
Since March 21, 2014, Lipocine's market cap has decreased from $82.30M to $54.41M, a decrease of -33.89%. That is a compound annual growth rate of -3.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2026 | 54.40M | 21.97% |
| Dec 31, 2025 | 44.60M | 70.88% |
| Dec 31, 2024 | 26.10M | 76.35% |
| Dec 29, 2023 | 14.80M | -57.95% |
| Dec 30, 2022 | 35.20M | -59.77% |
| Dec 31, 2021 | 87.50M | -2.02% |
| Dec 31, 2020 | 89.30M | 811.22% |
| Dec 31, 2019 | 9.80M | -64.87% |
| Dec 31, 2018 | 27.90M | -61.73% |
| Dec 29, 2017 | 72.90M | 8.48% |
| Dec 30, 2016 | 67.20M | -71.53% |
| Dec 31, 2015 | 236.00M | 250.67% |
| Dec 31, 2014 | 67.30M | -18.23% |
| Mar 21, 2014 | 82.30M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TScan Therapeutics | 57.32M |
| Tevogen Bio Holdings | 56.59M |
| PMV Pharmaceuticals | 55.34M |
| Radiopharm Theranostics | 55.13M |
| Metagenomi Therapeutics | 54.82M |
| NRx Pharmaceuticals | 54.47M |
| BeyondSpring | 53.46M |
| MiNK Therapeutics | 53.37M |